WMCC Clinical Trials

Home/WMCC Clinical Trials

Gastrointestinal System

A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair. (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer) EA2142: Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic [...]

Gastrointestinal System2020-03-06T15:05:50-04:00

Breast

A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (BWEL) A011502: A Randomized Phase III Double Blinded Placebo-Controlled Trial of Aspirin as Adjuvant Therapy for Node-Positive, HER2 Negative Breast Cancer: The Aspirin for Breast Cancer Study (ABC Study) A221505: Phase III Randomized [...]

Breast2020-03-03T12:14:09-04:00

Gynecologic

EAY131 (MATCH): Molecular Analysis for Therapy Choice GOG 0238: A randomized trial of pelvic irradiation with or without concurrent weekly cisplatin in patients with pelvic-only recurrence of carcinoma of the uterine corpus GOG 0263: Randomized phase III clinical trial of adjuvant radiation vs. chemoradiation in intermediate risk, stage I/IIA cervical cancer treated with initial radical hysterectomy [...]

Gynecologic2020-02-24T10:07:49-04:00

Genitourinary System

A031102: A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors – MALE GENDER ONLY. A031501: Phase III Randomized Adjuvant study of MK-3475 (Pembrolizumab) in muScle [...]

Genitourinary System2020-02-04T08:24:58-04:00

Head & Neck

EA3132: Phase II Randomized Trial of Adjuvant Radiotherapy with or without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) EA3161: A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA RTOG 1008: A Randomized Phase II Study of Adjuvant Concurrent [...]

Head & Neck2020-01-13T09:53:08-04:00

Sarcomas

No Clinical Trials Available

Sarcomas2020-01-13T11:05:06-04:00

Myeloma

A061202: A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Refractory to Lenalidomide and Proteasome Inhibitor-Based Therapy (Presently in Phase II)  

Myeloma2020-01-13T10:58:27-04:00

Multi-Site

9846: Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI) DCP-001: Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program EAY131 (MATCH): Molecular Analysis for Therapy Choice S1609: DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (For patients that did not have a match to a [...]

Multi-Site2020-01-13T10:37:22-04:00

Central Nervous System

A071601: Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngoimas N0577: CODEL: Phase III Intergroup Study of Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma

Central Nervous System2020-01-13T11:08:01-04:00

Lymphoma

Dana Farber: 14-174: Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome S1608: Randomized Phase II Study in Early Relapsing or Refractory Follicular Lymphoma S1826:  A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) with [...]

Lymphoma2020-01-13T10:49:10-04:00